[HTML][HTML] Targeting PI3K/AKT signaling pathway in obesity

MS Savova, LV Mihaylova, D Tews, M Wabitsch… - Biomedicine & …, 2023 - Elsevier
Obesity is a disorder with an increasing prevalence, which impairs the life quality of patients
and intensifies societal health care costs. The development of safe and innovative …

Lymphatic anomalies in children: update on imaging diagnosis, genetics, and treatment

EJ Snyder, A Sarma, AJ Borst… - American Journal of …, 2022 - Am Roentgen Ray Soc
Please see the Editorial Comment by Geetika Khanna discussing this article. Please see the
Author Video associated with this article. Lymphatic anomalies comprise a spectrum of …

Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib

G Morin, C Degrugillier-Chopinet, M Vincent… - Journal of Experimental …, 2022 - rupress.org
PIK3CA-related overgrowth spectrum (PROS) includes rare genetic conditions due to gain-
of-function mutations in the PIK3CA gene. There is no approved medical therapy for patients …

[HTML][HTML] Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth

TL Wenger, S Ganti, C Bull, E Lutsky, JT Bennett… - Genetics in …, 2022 - Elsevier
Purpose PIK3CA-related overgrowth spectrum (PROS) conditions of the head and neck are
treatment challenges. Traditionally, these conditions require multiple invasive interventions …

[HTML][HTML] Drug repurposing for rare: progress and opportunities for the rare disease community

AH Jonker, D O'Connor, M Cavaller-Bellaubi… - Frontiers in …, 2024 - frontiersin.org
Repurposing is one of the key opportunities to address the unmet rare diseases therapeutic
need. Based on cases of drug repurposing in small population conditions, and previous …

When, where and which PIK3CA mutations are pathogenic in congenital disorders

A Angulo-Urarte, M Graupera - Nature Cardiovascular Research, 2022 - nature.com
PIK3CA encodes the class I PI3Kα isoform and is frequently mutated in cancer. Activating
mutations in PIK3CA also cause a range of congenital disorders featuring asymmetric tissue …

Alpelisib to treat CLOVES syndrome, a member of the PIK3CA‐related overgrowth syndrome spectrum

G Garreta Fontelles, J Pardo Pastor… - British Journal of …, 2022 - Wiley Online Library
CLOVES syndrome is a rare congenital overgrowth disorder caused by mutations in the
phosphatidylinositol 3‐kinase catalytic subunit alpha (PIK3CA) gene. It is part of the PIK3CA …

[HTML][HTML] Lateralized and segmental overgrowth in children

A Mussa, D Carli, S Cardaropoli, GB Ferrero, N Resta - Cancers, 2021 - mdpi.com
Simple Summary Congenital lateralized or segmental overgrowth (LO) disorders are
conditions characterized by excessive tissue growth of a body region often associated with a …

[HTML][HTML] Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity

M Sterba, P Pokorna, R Faberova, B Pinkova… - Scientific reports, 2023 - nature.com
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …

[HTML][HTML] The genetic architecture of vascular anomalies: current data and future therapeutic perspectives correlated with molecular mechanisms

LI Butnariu, EV Gorduza, L Florea, E Țarcă… - International Journal of …, 2022 - mdpi.com
Vascular anomalies (VAs) are morphogenesis defects of the vascular system (arteries,
capillaries, veins, lymphatic vessels) singularly or in complex combinations, sometimes with …